My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine.

    Segura-Pacheco B, Perez-Cardenas E, Taja-Chayeb L, Chavez-Blanco A, Revilla-Vazquez A, Benitez-Bribiesca L, Duenas-González A.

    J Transl Med. 2006 Aug 7;4:32.PMID: 16893460 [PubMed]Related articlesFree article

    2.

    Relation of promoter methylation of mdr-1 gene and histone acetylation status with multidrug resistance in MCF-7/Adr cells.

    Huang C, Cao P, Xie Z.

    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 May;34(5):369-74.PMID: 19483282 [PubMed - in process]Related articlesFree article

    3.

    Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets.

    Chekhun VF, Lukyanova NY, Kovalchuk O, Tryndyak VP, Pogribny IP.

    Mol Cancer Ther. 2007 Mar;6(3):1089-98.PMID: 17363502 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil.

    Ye W, Chang HL, Wang LS, Huang YW, Shu S, Dowd MK, Wan PJ, Sugimoto Y, Lin YC.

    Anticancer Res. 2007 Jan-Feb;27(1A):107-16.PMID: 17352222 [PubMed - indexed for MEDLINE]Related articles

    6.

    Reversal of adriamycin resistance in human mammary cancer cells by small interfering RNA of MDR1 and MDR3 genes.

    Xiao L, Gao R, Lu S, Ren L, Wang Z.

    J Huazhong Univ Sci Technolog Med Sci. 2006;26(6):735-7.PMID: 17357504 [PubMed - in process]Related articles

    7.

    Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.

    Kars MD, Iseri OD, Gündüz U, Ural AU, Arpaci F, Molnár J.

    Anticancer Res. 2006 Nov-Dec;26(6B):4559-68.PMID: 17201178 [PubMed - indexed for MEDLINE]Related articles

    8.

    Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase.

    Benbrahim-Tallaa L, Waterland RA, Dill AL, Webber MM, Waalkes MP.

    Environ Health Perspect. 2007 Oct;115(10):1454-9.PMID: 17938735 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis.

    Jin J, Sun H, Wei H, Liu G.

    Invest New Drugs. 2007 Apr;25(2):95-105.PMID: 16937080 [PubMed - indexed for MEDLINE]Related articles

    10.

    DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.

    Roll JD, Rivenbark AG, Jones WD, Coleman WB.

    Mol Cancer. 2008 Jan 25;7:15.PMID: 18221536 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil.

    Zhang L, Yang Y, Wei XY, Shi YR, Liu HY, Niu RF, Hao XS.

    J Exp Clin Cancer Res. 2007 Jun;26(2):201-7.PMID: 17725099 [PubMed - indexed for MEDLINE]Related articles

    12.

    In vitro evaluation of zoledronic acid resistance developed in MCF-7 cells.

    Kars MD, Işeri OD, Ural AU, Gündüz U.

    Anticancer Res. 2007 Nov-Dec;27(6B):4031-7.PMID: 18225567 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Chemosensitivity of mdr1 gene overexpressed multidrug resistant cancer cells to lidamycin]

    Shi YK, Wu SY, Huang YH, Zhen YS.

    Yao Xue Xue Bao. 2006 Dec;41(12):1146-51. Chinese. PMID: 17290610 [PubMed - indexed for MEDLINE]Related articles

    15.

    The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells.

    Liu F, Xie ZH, Cai GP, Jiang YY.

    Biol Pharm Bull. 2007 Dec;30(12):2279-83.PMID: 18057712 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.

    Liu F, Fan D, Qi J, Zhu H, Zhou Y, Yang C, Zhu Z, Xiong D.

    Life Sci. 2008 Sep 26;83(13-14):496-501. Epub 2008 Aug 3.PMID: 18725232 [PubMed - indexed for MEDLINE]Related articles

    17.

    Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells.

    Mutoh K, Tsukahara S, Mitsuhashi J, Katayama K, Sugimoto Y.

    Cancer Sci. 2006 Nov;97(11):1198-204. Epub 2006 Aug 22.PMID: 16925584 [PubMed - indexed for MEDLINE]Related articles

    18.

    Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells.

    Han CY, Cho KB, Choi HS, Han HK, Kang KW.

    Carcinogenesis. 2008 Sep;29(9):1837-44. Epub 2008 Apr 4.PMID: 18390843 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Biophysical characterization of MDR breast cancer cell lines reveals the cytoplasm is critical in determining drug sensitivity.

    Coley HM, Labeed FH, Thomas H, Hughes MP.

    Biochim Biophys Acta. 2007 Apr;1770(4):601-8. Epub 2006 Dec 16.PMID: 17270349 [PubMed - indexed for MEDLINE]Related articles

    20.

    Breast cancer epigenetics: from DNA methylation to microRNAs.

    Veeck J, Esteller M.

    J Mammary Gland Biol Neoplasia. 2010 Mar;15(1):5-17. Epub 2010 Jan 27.PMID: 20101446 [PubMed - in process]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk